CoChat
Sign Up
Cited by 221

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Allorecognition by T Lymphocytes and Allograft Rejection

Marino, Jose, Paster, Joshua, Benichou, Gilles·2016·Frontiers in Immunology
DOI 10.3389/fimmu.2016.00582PMC PMC5155009
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2016.00582

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Potential mechanisms involved in semi-direct allorecognition by recipient CD4+ and CD8+ T cells. Recipient cells are shown in blue and donor cells and peptides are shown in red. (A) depicts the classical four-cell cluster model in which CD4+ T cells activated indirectly [via recognition of recipient major histocompatibility complex (MHC) class II+ donor peptide, displayed on recipient antigen-presenting cells (APCs)] may provide help for CD8+ T cells activated directly (via recognition of donor MHC class I on donor APCs). (C) depicts the traditional four-cell cluster model in which CD4+ T cells activated indirectly (via recognition of recipient MHC class II+ donor peptide, displayed on recipient APCs) and CD4+ T cells activated directly (via recognition of donor MHC class II on donor APCs). (B,D) describe different mechanisms by which semi-direct allorecognition could allow for a three-cell cluster model in which different T cells recognize different antigens on the same recipient APCs. This process would optimize T cell help by CD4+ T cells activated indirectly for CD8+ T cell activated directly (recognition of acquired MHC class I) (B) and enhance cooperation between CD4+ T cells activated directly (via recognition of acquired donor MHC class II) and indirectly (recipient MHC class II+ donor peptide) (D).
Figure 1 Potential mechanisms involved in semi-direct allorecognition by recipient CD4+ and CD8+ T cells. Recipient cells are shown in blue and donor cells and peptides are shown in red. (A) depicts the classical four-cell cluster model in which CD4+ T cells activated indirectly [via recognition of recipient major histocompatibility complex (MHC) class II+ donor peptide, displayed on recipient antigen-presenting cells (APCs)] may provide help for CD8+ T cells activated directly (via recognition of donor MHC class I on donor APCs). (C) depicts the traditional four-cell cluster model in which CD4+ T cells activated indirectly (via recognition of recipient MHC class II+ donor peptide, displayed on recipient APCs) and CD4+ T cells activated directly (via recognition of donor MHC class II on donor APCs). (B,D) describe different mechanisms by which semi-direct allorecognition could allow for a three-cell cluster model in which different T cells recognize different antigens on the same recipient APCs. This process would optimize T cell help by CD4+ T cells activated indirectly for CD8+ T cell activated directly (recognition of acquired MHC class I) (B) and enhance cooperation between CD4+ T cells activated directly (via recognition of acquired donor MHC class II) and indirectly (recipient MHC class II+ donor peptide) (D).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 113

  1. Rosa, 2010, Hydractinia allodeterminant alr1 resides in an immunoglobulin superfamily-like gene complex, Curr Biol, 20, 1122, 10.1016/j.cub.2010.04.050 · DOI
  2. Kroemer, 2008, The innate natural killer cells in transplant rejection and tolerance induction, Curr Opin Organ Transplant, 13, 339, 10.1097/MOT.0b013e3283061115 · DOI
  3. Oberbarnscheidt, 2011, The innate immune system in transplantation, Semin Immunol, 23, 264, 10.1016/j.smim.2011.06.006 · DOI
  4. Wood, 2003, Regulatory T cells in transplantation tolerance, Nat Rev Immunol, 3, 199, 10.1038/nri1027 · DOI
  5. Wekerle, 2002, Mechanisms of transplant tolerance induction using costimulatory blockade, Curr Opin Immunol, 14, 592, 10.1016/S0952-7915(02)00378-3 · DOI
  6. Barker, 1968, The role of afferent lymphatics in the rejection of skin homografts, J Exp Med, 128, 197, 10.1084/jem.128.1.197 · DOI
  7. Steinmuller, 1980, Passenger leukocytes and the immunogenicity of skin allografts, J Invest Dermatol, 75, 107, 10.1111/1523-1747.ep12521331 · DOI
  8. Billingham, 1971, The passenger cell concept in transplantation immunology, Cell Immunol, 2, 1, 10.1016/0008-8749(71)90022-0 · DOI
  9. Rosenberg, 1992, Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction, Annu Rev Immunol, 10, 333, 10.1146/annurev.iy.10.040192.002001 · DOI
  10. Lindahl, 1977, Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors, J Exp Med, 145, 508, 10.1084/jem.145.3.508 · DOI
  11. Ashwell, 1986, High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules, J Immunol, 136, 389, 10.4049/jimmunol.136.2.389 · DOI
  12. Suchin, 2001, Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question, J Immunol, 166, 973, 10.4049/jimmunol.166.2.973 · DOI
  13. Benichou, 1999, Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice, J Immunol, 162, 352, 10.4049/jimmunol.162.1.352 · DOI
  14. Rogers, 2001, Allorecognition, Am J Transplant, 1, 97, 10.1034/j.1600-6143.2001.10201.x · DOI
  15. Lechler, 1990, The molecular basis of alloreactivity, Immunol Today, 11, 83, 10.1016/0167-5699(90)90033-6 · DOI
  16. Hogquist, 1994, T cell receptor antagonist peptides induce positive selection, Cell, 76, 17, 10.1016/0092-8674(94)90169-4 · DOI
  17. Adams, 2003, Heterologous immunity: an overlooked barrier to tolerance, Immunol Rev, 196, 147, 10.1046/j.1600-065X.2003.00082.x · DOI
  18. Taylor, 2004, Heterologous immunity and homeostatic proliferation as barriers to tolerance, Curr Opin Immunol, 16, 558, 10.1016/j.coi.2004.07.007 · DOI
  19. Amir, 2010, Allo-HLA reactivity of virus-specific memory T cells is common, Blood, 115, 3146, 10.1182/blood-2009-07-234906 · DOI
  20. Brehm, 2003, Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections, J Immunol, 170, 4077, 10.4049/jimmunol.170.8.4077 · DOI
  21. Pantenburg, 2002, T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection, J Immunol, 169, 3686, 10.4049/jimmunol.169.7.3686 · DOI
  22. Golding, 1984, Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses, J Immunol, 133, 597, 10.4049/jimmunol.133.2.597 · DOI
  23. Lechler, 1982, Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient, J Exp Med, 156, 1835, 10.1084/jem.156.6.1835 · DOI
  24. Lechler, 1982, Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells, J Exp Med, 155, 31, 10.1084/jem.155.1.31 · DOI
  25. Benichou, 1990, Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides, J Exp Med, 172, 1341, 10.1084/jem.172.5.1341 · DOI
  26. Liu, 1992, T cell recognition of allopeptides in context of syngeneic MHC, J Immunol, 148, 35, 10.4049/jimmunol.148.1.35 · DOI
  27. Fangmann, 1992, T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection, Eur J Immunol, 22, 1525, 10.1002/eji.1830220627 · DOI
  28. Popov, 1995, Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation, Transplantation, 60, 1621
  29. Valujskikh, 2001, Indirectly primed CD8+ T cells are a prominent component of the allogeneic T-cell repertoire after skin graft rejection in mice, Transplantation, 71, 418, 10.1097/00007890-200102150-00014 · DOI
  30. Valujskikh, 2002, Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway, Nat Immunol, 3, 844, 10.1038/ni831 · DOI
  31. Benichou, 1994, Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation, J Immunol, 153, 938, 10.4049/jimmunol.153.3.938 · DOI
  32. Liu, 1993, Limited usage of T cell receptor V beta genes by allopeptide-specific T cells, J Immunol, 150, 3180, 10.4049/jimmunol.150.8.3180 · DOI
  33. Boisgerault, 2000, Induction of T-cell response to cryptic MHC determinants during allograft rejection, Hum Immunol, 61, 1352, 10.1016/S0198-8859(00)00209-3 · DOI
  34. Sercarz, 1993, Dominance and crypticity of T cell antigenic determinants, Annu Rev Immunol, 11, 729, 10.1146/annurev.iy.11.040193.003501 · DOI
  35. Lehmann, 1992, Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen, Nature, 358, 155, 10.1038/358155a0 · DOI
  36. Lehmann, 1993, Determinant spreading and the dynamics of the autoimmune T-cell repertoire [see comments], Immunol Today, 14, 203, 10.1016/0167-5699(93)90163-F · DOI
  37. Suciu-Foca, 1998, Intramolecular and intermolecular spreading during the course of organ allograft rejection, Immunol Rev, 164, 241, 10.1111/j.1600-065X.1998.tb01224.x · DOI
  38. Goulmy, 1996, Human minor histocompatibility antigens, Curr Opin Immunol, 8, 75, 10.1016/S0952-7915(96)80108-7 · DOI
  39. Brown, 2008, Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation, FASEB J, 22, 3776, 10.1096/fj.08-107441 · DOI
  40. Thery, 2002, Exosomes: composition, biogenesis and function, Nat Rev Immunol, 2, 569, 10.1038/nri855 · DOI
  41. Hudson, 1976, Specific adsorption of IgM antibody onto H-2-activated mouse T lymphocytes, J Exp Med, 143, 444, 10.1084/jem.143.2.444 · DOI
  42. Bona, 1973, Transfer of antigen from macrophages to lymphocytes. II. Immunological significance of the transfer of lipopolysaccharide, Immunology, 24, 831
  43. Frelinger, 1974, Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes, J Exp Med, 140, 1273, 10.1084/jem.140.5.1273 · DOI
  44. Dolan, 2006, Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells, J Immunol, 177, 6018, 10.4049/jimmunol.177.9.6018 · DOI
  45. Brown, 2010, Intercellular exchange of surface molecules and its physiological relevance, Arch Immunol Ther Exp (Warsz), 58, 263, 10.1007/s00005-010-0085-y · DOI
  46. Harper, 2015, CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection, Proc Natl Acad Sci U S A, 112, 12788, 10.1073/pnas.1513533112 · DOI
  47. Markey, 2014, Cross-dressing by donor dendritic cells after allogeneic bone marrow transplantation contributes to formation of the immunological synapse and maximizes responses to indirectly presented antigen, J Immunol, 192, 5426, 10.4049/jimmunol.1302490 · DOI
  48. Herrera, 2004, A novel pathway of alloantigen presentation by dendritic cells, J Immunol, 173, 4828, 10.4049/jimmunol.173.8.4828 · DOI
  49. Smyth, 2006, A novel pathway of antigen presentation by dendritic and endothelial cells: implications for allorecognition and infectious diseases, Transplantation, 82, S15, 10.1097/01.tp.0000231347.06149.ca · DOI
  50. Russo, 2000, Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells, Blood, 95, 3473, 10.1182/blood.V95.11.3473 · DOI
  51. Benichou, 2011, Immune recognition and rejection of allogeneic skin grafts, Immunotherapy, 3, 757, 10.2217/imt.11.2 · DOI
  52. Benichou, 1999, Direct and indirect antigen recognition: the pathways to allograft immune rejection, Front Biosci, 4, D476, 10.2741/A442 · DOI
  53. Auchincloss, 1993, The role of “indirect” recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice, Proc Natl Acad Sci U S A, 90, 3373, 10.1073/pnas.90.8.3373 · DOI
  54. Lee, 1994, Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo, J Exp Med, 179, 865, 10.1084/jem.179.3.865 · DOI
  55. Valujskikh, 2000, CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferon-gamma, Transplantation, 69, 1016, 10.1097/00007890-200003150-00063 · DOI
  56. Valujskikh, 2001, A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen, Transplantation, 72, 685, 10.1097/00007890-200108270-00022 · DOI
  57. Marino, 2016, Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation, Sci Immunol, 1, 1, 10.1126/sciimmunol.aaf8759 · DOI
  58. Smyth, 2016, Continuous acquisition of MHC:peptide complexes by recipient cells contributes to the generation of anti-graft CD8+ T cell immunity, Am J Transplant, 16, 1, 10.1111/ajt.13996 · DOI
  59. Kant, 2013, Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis, J Immunol, 191, 1948, 10.4049/jimmunol.1202092 · DOI
  60. Sano, 1996, Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice, Transpl Immunol, 4, 53, 10.1016/S0966-3274(96)80035-9 · DOI
  61. Streilein, 1999, Immunologic privilege of the eye, Springer Semin Immunopathol, 21, 95, 10.1007/BF00810243 · DOI
  62. Streilein, 1979, Corneal allografts fail to express Ia antigens, Nature, 282, 326, 10.1038/282326a0 · DOI
  63. Whitsett, 1984, The distribution of HLA antigens on human corneal tissue, Invest Ophthalmol Vis Sci, 25, 519
  64. Bartlett, 1983, Influence of culturing on the survival of major histocompatibility complex-compatible and -incompatible thyroid grafts in rats, J Exp Med, 157, 348, 10.1084/jem.157.1.348 · DOI
  65. Boisgerault, 2001, Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation, J Immunol, 167, 1891, 10.4049/jimmunol.167.4.1891 · DOI
  66. Boisgerault, 2009, Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants, Transplantation, 87, 16, 10.1097/TP.0b013e318191b38b · DOI
  67. Liu, 2002, Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts, J Exp Med, 195, 259, 10.1084/jem.20010838 · DOI
  68. Hamrah, 2003, The corneal stroma is endowed with a significant number of resident dendritic cells, Invest Ophthalmol Vis Sci, 44, 581, 10.1167/iovs.02-0838 · DOI
  69. Huq, 2004, Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment, J Immunol, 173, 4464, 10.4049/jimmunol.173.7.4464 · DOI
  70. Matoba, 1986, T cell subsets in the immune rejection of murine heterotopic corneal allografts, Invest Ophthalmol Vis Sci, 27, 1244
  71. Krieger, 1996, CD4+ but not CD8+ cells are essential for allorejection, J Exp Med, 184, 2013, 10.1084/jem.184.5.2013 · DOI
  72. Trager, 1989, Cardiac allograft prolongation in mice treated with combined posttransplantation total-lymphoid irradiation and anti-L3T4 antibody therapy, Transplantation, 47, 587, 10.1097/00007890-198904000-00004 · DOI
  73. Corry, 1973, Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection, Transplantation, 16, 343, 10.1097/00007890-197310000-00010 · DOI
  74. Larsen, 1990, Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection, J Exp Med, 171, 307, 10.1084/jem.171.1.307 · DOI
  75. Wang, 2004, Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time, J Immunol, 172, 5924, 10.4049/jimmunol.172.10.5924 · DOI
  76. Su, 2014, Endogenous memory CD8 T cells directly mediate cardiac allograft rejection, Am J Transplant, 14, 568, 10.1111/ajt.12605 · DOI
  77. Obhrai, 2006, Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs, J Immunol, 176, 4051, 10.4049/jimmunol.176.7.4051 · DOI
  78. Valujskikh, 2003, In remembrance of things past: memory T cells and transplant rejection, Immunol Rev, 196, 65, 10.1046/j.1600-065X.2003.00087.x · DOI
  79. Nadazdin, 2010, Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys, Am J Transplant, 10, 1375, 10.1111/j.1600-6143.2010.03119.x · DOI
  80. Nadazdin, 2011, Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates, Sci Transl Med, 3, 86ra51, 10.1126/scitranslmed.3002093 · DOI
  81. Heeger, 1999, Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes, J Immunol, 163, 2267, 10.4049/jimmunol.163.4.2267 · DOI
  82. Hricik, 2003, Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients, Am J Transplant, 3, 878, 10.1034/j.1600-6143.2003.00132.x · DOI
  83. Lee, 2001, Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy, Proc Natl Acad Sci U S A, 98, 3276, 10.1073/pnas.051584498 · DOI
  84. Baker, 2001, Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy, J Immunol, 167, 7199, 10.4049/jimmunol.167.12.7199 · DOI
  85. Hornick, 2000, Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection, Circulation, 101, 2405, 10.1161/01.CIR.101.20.2405 · DOI
  86. Suciu-Foca, 1996, Role of indirect allorecognition in chronic rejection of human allografts, Transplant Proc, 28, 404
  87. Najafian, 2002, Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients, J Am Soc Nephrol, 13, 252, 10.1681/ASN.V131252 · DOI
  88. Vacchio, 1999, The fetus and the maternal immune system: pregnancy as a model to study peripheral T-cell tolerance, Crit Rev Immunol, 19, 461
  89. Ait-Azzouzene, 1998, Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy, J Immunol, 161, 2677, 10.4049/jimmunol.161.6.2677 · DOI
  90. Niederkorn, 1990, Immune privilege and immune regulation in the eye, Adv Immunol, 48, 191, 10.1016/S0065-2776(08)60755-5 · DOI
  91. Nasr, 2005, Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells, J Immunol, 174, 6161, 10.4049/jimmunol.174.10.6161 · DOI
  92. Cobbold, 2006, Immune privilege induced by regulatory T cells in transplantation tolerance, Immunol Rev, 213, 239, 10.1111/j.1600-065X.2006.00428.x · DOI
  93. Wekerle, 2001, Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death, J Immunol, 166, 2311, 10.4049/jimmunol.166.4.2311 · DOI
  94. LaRosa, 2007, The innate immune system in allograft rejection and tolerance, J Immunol, 178, 7503, 10.4049/jimmunol.178.12.7503 · DOI
  95. Waldmann, 2004, Regulatory T cells and organ transplantation, Semin Immunol, 16, 119, 10.1016/j.smim.2003.12.007 · DOI
  96. Sakaguchi, 2008, Regulatory T cells and immune tolerance, Cell, 133, 775, 10.1016/j.cell.2008.05.009 · DOI
  97. Sakaguchi, 2010, FOXP3+ regulatory T cells in the human immune system, Nat Rev Immunol, 10, 490, 10.1038/nri2785 · DOI
  98. Shevach, 2001, Control of T-cell activation by CD4+ CD25+ suppressor T cells, Immunol Rev, 182, 58, 10.1034/j.1600-065X.2001.1820104.x · DOI
  99. Sakaguchi, 2001, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol Rev, 182, 18, 10.1034/j.1600-065X.2001.1820102.x · DOI
  100. Shevach, 2001, Control of autoimmunity by regulatory T cells, Adv Exp Med Biol, 490, 21, 10.1007/978-1-4615-1243-1_3 · DOI
  101. Graca, 2002, Identification of regulatory T cells in tolerated allografts, J Exp Med, 195, 1641, 10.1084/jem.20012097 · DOI
  102. Miyajima, 2011, Early acceptance of renal allografts in mice is dependent on foxp3(+) cells, Am J Pathol, 178, 1635, 10.1016/j.ajpath.2010.12.024 · DOI
  103. Josefowicz, 2009, Control of regulatory T cell lineage commitment and maintenance, Immunity, 30, 616, 10.1016/j.immuni.2009.04.009 · DOI
  104. LeGuern, 2003, Regulation of T-cell functions by MHC class II self-presentation, Trends Immunol, 24, 633, 10.1016/j.it.2003.10.010 · DOI
  105. LeGuern, 1995, Retrovirus-mediated transfer of MHC class II cDNA into swine bone marrow cells, J Mol Med (Berl), 73, 269, 10.1007/BF00231613 · DOI
  106. Germana, 1997, Retroviral vectors transfer functional MHC class II heterodimers into bone marrow: a genetic approach to tolerance induction, Transplant Proc, 29, 1129, 10.1016/S0041-1345(96)00463-0 · DOI
  107. Sonntag, 2001, Tolerance to solid organ transplants through transfer of MHC class II genes, J Clin Invest, 107, 65, 10.1172/JCI11015 · DOI
  108. LeGuern, 2004, Potential role of major histocompatibility complex class II peptides in regulatory tolerance to vascularized grafts, Transplantation, 77, S35, 10.1097/01.TP.0000106472.91343.8D · DOI
  109. LeGuern, 2010, Intracellular MHC class II controls regulatory tolerance to allogeneic transplants, J Immunol, 184, 2394, 10.4049/jimmunol.0803664 · DOI
  110. Wing, 2010, Regulatory T cells exert checks and balances on self tolerance and autoimmunity, Nat Immunol, 11, 7, 10.1038/ni.1818 · DOI
  111. Ochando, 2006, Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts, Nat Immunol, 7, 652, 10.1038/ni1333 · DOI
  112. Ezzelarab, 2011, Tolerogenic dendritic cells and their role in transplantation, Semin Immunol, 23, 252, 10.1016/j.smim.2011.06.007 · DOI
  113. McCurry, 2006, Regulatory dendritic cell therapy in organ transplantation, Transpl Int, 19, 525, 10.1111/j.1432-2277.2006.00306.x · DOI

Cited by

Metadata

Authors
Marino, J., Paster, J., & Benichou, G.
Venue
Frontiers in Immunology
Publisher
Frontiers Media SA
Published
2016-12-14
Volume
7
ISSN
1664-3224
DOI
10.3389/fimmu.2016.00582
PMC
PMC5155009
Cited by
221
References
4
Funders
National Institutes of Health (R21AI111191 and R21AI117466)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review